American International Group’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
– Sell
-2,388
Closed -$52K – 4191
2016
Q1
$52K Sell
2,388
-186
-7% -$4.25K ﹤0.01% 3868
2015
Q4
$81K Buy
2,574
+1,323
+106% +$40.5K ﹤0.01% 3638
2015
Q3
$35K Buy
1,251
+690
+123% +$24.1K ﹤0.01% 4078
2015
Q2
$19.9K Buy
561
+411
+274% +$13.4K ﹤0.01% 4380
2015
Q1
$4.48K Buy
+150
New +$4.22K ﹤0.01% 4725

Other funds holding SBIO

American International Group's SBIO Position: Q2 2016 in Review

American International Group sold out of ALPS Medical Breakthroughs ETF (SBIO) in Q2 2016, closing a stake of 2,388 shares — an estimated $52K sold.

American International Group first reported a position in SBIO in Q1 2015 and held it in 5 quarters. The position peaked at $81K in Q4 2015. 27 funds tracked by Wall St. Rank hold SBIO as of Q2 2016.

  • American International Group reported no remaining ALPS Medical Breakthroughs ETF position as of Q2 2016 after selling out during the quarter.
  • American International Group sold 2,388 ALPS Medical Breakthroughs ETF shares in Q2 2016, an estimated $52K.
  • American International Group first reported a position in ALPS Medical Breakthroughs ETF in Q1 2015 and held it in 5 quarters.
  • American International Group's ALPS Medical Breakthroughs ETF position peaked at $81K in Q4 2015.
  • 27 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q2 2016.

Based on American International Group's 13F filing for Q2 2016, filed 11 Aug 2016.